|Ms. Janelle D'Alvise||Pres, CEO, Corp. Sec. & Director||428.04k||N/A||1955|
|Dr. Pierre Lemieux||Co-Founder, COO & Chief Scientific Officer||276.38k||N/A||1965|
|Mr. Brian D. Ford CPA, CA||Chief Financial Officer||364.82k||N/A||1959|
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre, an omega-3 phospholipid therapeutic to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Acasti Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.